AR and prostate cancer: Our functional analyses further revealed that the TLX-induced androgen insensitivity was mediated through its direct repression of AR gene transcription and suppression of AR transcriptional activity in prostate cancer cells via a mechanism of recruitment of chromatin modifiers HDACs and LSD1 to the TLX-binding motifs at the AR gene promoter.